Person-Centered Web-Based Mobile Health System (Symptoms) for Reporting Symptoms in COVID-19 Vaccinated Individuals: Observational Study of System, Users, and Symptoms (Preprint) DOI
Emelie Gustafson, Fredrik Nyberg, Stefan Gustafsson

и другие.

Опубликована: Фев. 20, 2024

BACKGROUND The full spectrum of side effects from COVID-19 vaccinations and infections, including milder symptoms or health that do not lead to care visits, remains unknown. Person-centered self-reporting may offer a solution. Monitoring patient-reported outcomes over time will vary in importance for different patients. Individuals have unique needs preferences, terms both communication methods how the collected information is used support care. OBJECTIVE This study aims describe Symptoms, system person-centered health-related quality life, was utilized investigating vaccine effects. We illustrate this by presenting data Symptoms newly vaccinated individuals RECOVAC (Register-based large-scale national population monitor vaccination effectiveness safety) study. METHODS During pandemic, were identified as ideal query related infections. To end, we posters observation areas at 150 sites across Västra Götaland region Sweden, inviting use novel digital system, Symptoms. In users can track their symptoms, functioning, life often they wish, using evidence-based outcome measures short numeric rating scales. These scales cover prespecified list based on common previously reported Participants could also self-defined if symptom included list. RESULTS A total 731 people created user accounts consented share research between July 21, 2021, September 27, 2022. majority female (444/731, 60.7%), with median age 38 (IQR 30-47) years. Most participants (498/702, 70.9%) did report any comorbidities questionnaire. Of participants, 563 (77.0%) experiencing 1 more symptoms. most pain injection site (486/563, 86.3%), followed fatigue (181/563, 32.1%) headache (169/563, 30.0%). total, 143 reported. these, 29 list, while remaining 114 (79.7%) entries field. suggests flexibility self-directed system—allowing decide which consider worth tracking—may be an important feature. CONCLUSIONS Self-reported appeared align observed post–COVID-19 relatively easy successfully captured broad, longitudinal data. Its design seemed crucial capturing burden experienced users.

Язык: Английский

Exploring Adverse Events Following COVID-19 Vaccination and Community Anxiety in Banda Aceh, Indonesia DOI Creative Commons
Cut Husna, Nabila Putri, Laras Cyntia Kasih

и другие.

Journal of Liaquat University of Medical & Health Sciences, Год журнала: 2024, Номер unknown, С. 38 - 45

Опубликована: Янв. 30, 2024

OBJECTIVE: This study aimed to explore the relationship between Adverse events following immunization (AEFI) reaction and community anxiety levels related COVID-19 vaccine.METHODOLOGY: A retrospective correlational was conducted.The sample comprised 344 individuals who received two doses of vaccine resided in Syiah Kuala sub-district Banda Aceh.Data collection facilitated through administration "Post-Immunization Events" "Beck Anxiety Inventory (BAI)" questionnaires were utilized.Spearman's rank test analyzed data.RESULTS: The findings this demonstrated a significant AEFI dose 1 (p = 0.025), 2 0.000), local reactions 0.004), 0.016), systemic 0.002), with community' levels.CONCLUSION: refers medical vaccination effect consisting reactions.AEFI may potentially elevate community's anxiety.The noted an increase severe symptoms decrease during second vaccine, possibly attributed variations antibody titers community.It is recommended that patients pay attention seek immediate support from hospital if excessive appear, for healthcare workers could provide educational programs regarding risks efforts look treatment.

Язык: Английский

Процитировано

0
Investigation of adverse effects following COVID-19 immunization: A comparison of six vaccines in Pakistan DOI

Ayesha Sana,

Saba Noor,

Kashif Iqbal

и другие.

Deleted Journal, Год журнала: 2024, Номер 2(2), С. 1372 - 1372

Опубликована: Июль 19, 2024

Aim: This survey was created to find out the prevalence of immunized people and its objectives include evaluating how general public responded six different COVID-19 vaccination range severity vaccine adverse effects that participants self-reported. Methodology: A cross-sectional using questionnaires carried out. The development proper validation a self-administered questionnaire were completed. SPSS version 23.0 used analyze data. For statistical evaluation, descriptive analysis determine demographic frequency percentage, other questions, effects. Analysis associations between study variables done chi-square tests. Each participant gave verbal consent before collection participants’ confidentiality protected. Results: total 493 enrolled in study, with 42.6% them falling age 21 30 years. had acquired vaccinations; these, 25.96% obtained Sinopharm, 22.31% received Cansino Pakvac, 16.63% Pfizer, 12.57% given Sinovac, 11.96% Moderna, 10.54% AstraZeneca. These vaccines’ most significant included injection site pain, fever, headache, weariness, myalgia, joint chills. Conclusion: Even though after receiving first dose vaccination, over 55% those who it reported musculoskeletal side effects, such as muscle aches fatigue, we found generally accepted vaccination. After obtaining second shot, observed did not have many

Язык: Английский

Процитировано

0
Influence of previous COVID-19 exposure and vaccine type (CoronaVac, ChAdOx1 nCov-19 or BNT162b2) on antibody and cytokine (Th1 or Th2) responses DOI Creative Commons
Diana Lourdes Padilla-Bórquez, Mónica Guadalupe Matuz-Flores, Jorge Hernández‐Bello

и другие.

Human Vaccines & Immunotherapeutics, Год журнала: 2024, Номер 20(1)

Опубликована: Сен. 9, 2024

To achieve global herd immunity, widespread vaccination is the most effective strategy. Vaccines stimulate immune system, generating cytokines and chemokines, isotype antibodies, neutralizing antibodies; all these molecules collectively provide a more comprehensive characterization of response post-vaccination. We conducted longitudinal study in northwestern Mexico, involving 120 individuals before after first dose SARS-CoV-2 vaccine, 46 their second dose. Our findings reveal that antibody levels stabilize over time; cytokine generally increase following but decrease higher than normal IgG1 IgG3 concentrations are present. Most innate determined this were vaccine. Regardless previous infection history, finding suggests vaccine crucial may immunity by enhancing response. Conversely, increased IL-4, indicative Th2 response, found without prior exposure to virus those vaccinated with CoronaVac. These results suggest COVID-19 vaccines multi-faceted, preexisting potentiating robust Vaccine type plays critical role, genetic favoring Th1 inactivated like CoronaVac skewing toward profile.

Язык: Английский

Процитировано

0
Use of the person-centered web-based mhealth system Symptoms for reporting symptoms in Covid-19 vaccinated individuals: descriptions of system, study, and data (Preprint) DOI Creative Commons
Emelie Gustafson, Fredrik Nyberg, Stefan Gustafsson

и другие.

JMIR Formative Research, Год журнала: 2024, Номер 8, С. e57514 - e57514

Опубликована: Сен. 23, 2024

Background The full spectrum of side effects from COVID-19 vaccinations and infections, including milder symptoms or health that do not lead to care visits, remains unknown. Person-centered self-reporting may offer a solution. Monitoring patient-reported outcomes over time will vary in importance for different patients. Individuals have unique needs preferences, terms both communication methods how the collected information is used support care. Objective This study aims describe Symptoms, system person-centered health-related quality life, was utilized investigating vaccine effects. We illustrate this by presenting data Symptoms newly vaccinated individuals RECOVAC (Register-based large-scale national population monitor vaccination effectiveness safety) study. Methods During pandemic, were identified as ideal query related infections. To end, we posters observation areas at 150 sites across Västra Götaland region Sweden, inviting use novel digital system, Symptoms. In users can track their symptoms, functioning, life often they wish, using evidence-based outcome measures short numeric rating scales. These scales cover prespecified list based on common previously reported Participants could also self-defined if symptom included list. Results A total 731 people created user accounts consented share research between July 21, 2021, September 27, 2022. majority female (444/731, 60.7%), with median age 38 (IQR 30-47) years. Most participants (498/702, 70.9%) did report any comorbidities questionnaire. Of participants, 563 (77.0%) experiencing 1 more symptoms. most pain injection site (486/563, 86.3%), followed fatigue (181/563, 32.1%) headache (169/563, 30.0%). total, 143 reported. these, 29 list, while remaining 114 (79.7%) entries field. suggests flexibility self-directed system—allowing decide which consider worth tracking—may be an important feature. Conclusions Self-reported appeared align observed post–COVID-19 relatively easy successfully captured broad, longitudinal data. Its design seemed crucial capturing burden experienced users.

Язык: Английский

Процитировано

0
Person-Centered Web-Based Mobile Health System (Symptoms) for Reporting Symptoms in COVID-19 Vaccinated Individuals: Observational Study of System, Users, and Symptoms (Preprint) DOI
Emelie Gustafson, Fredrik Nyberg, Stefan Gustafsson

и другие.

Опубликована: Фев. 20, 2024

BACKGROUND The full spectrum of side effects from COVID-19 vaccinations and infections, including milder symptoms or health that do not lead to care visits, remains unknown. Person-centered self-reporting may offer a solution. Monitoring patient-reported outcomes over time will vary in importance for different patients. Individuals have unique needs preferences, terms both communication methods how the collected information is used support care. OBJECTIVE This study aims describe Symptoms, system person-centered health-related quality life, was utilized investigating vaccine effects. We illustrate this by presenting data Symptoms newly vaccinated individuals RECOVAC (Register-based large-scale national population monitor vaccination effectiveness safety) study. METHODS During pandemic, were identified as ideal query related infections. To end, we posters observation areas at 150 sites across Västra Götaland region Sweden, inviting use novel digital system, Symptoms. In users can track their symptoms, functioning, life often they wish, using evidence-based outcome measures short numeric rating scales. These scales cover prespecified list based on common previously reported Participants could also self-defined if symptom included list. RESULTS A total 731 people created user accounts consented share research between July 21, 2021, September 27, 2022. majority female (444/731, 60.7%), with median age 38 (IQR 30-47) years. Most participants (498/702, 70.9%) did report any comorbidities questionnaire. Of participants, 563 (77.0%) experiencing 1 more symptoms. most pain injection site (486/563, 86.3%), followed fatigue (181/563, 32.1%) headache (169/563, 30.0%). total, 143 reported. these, 29 list, while remaining 114 (79.7%) entries field. suggests flexibility self-directed system—allowing decide which consider worth tracking—may be an important feature. CONCLUSIONS Self-reported appeared align observed post–COVID-19 relatively easy successfully captured broad, longitudinal data. Its design seemed crucial capturing burden experienced users.

Язык: Английский

Процитировано

0